Biosimilars Conference 2015

The Biosimilars Conference 2015 provides knowledge on the current status for biosimilars in EU and internationally with a focus on regulatory and scientific challenges as well as market access.

Key Topics

• International development of biosimilars
• Current regulatory status of biosimilars in the EU
• Pharmacovigilance issues related to biosimilars – EU and globally
• Naming of biologicals including biosimilars
• Market experience with biosimilars including market access and pricing Patient and physicians approach to use of biosimilars

Who should Attend

Attendees from:

• The pharmaceutical industry and service providers including
  • Pharmacovigilance staff
  • Regulatory affairs personnel
  • Clinical and medical personnel
• Regulatory agencies
• Physicians and their scientific societies
• Academic institutions
• Patients organisations